Want to join the conversation?
Biotechnology company $SPPI announced its divestment rights of ZEVALIN (ibritumomab tiuxetan) in Japan & other countries in APAC, Middle East, Africa & Latin America to Mundipharma. $SPPI will receive $15MM as an up-front payment & $5MM as profits. $SPPI continues to own ZEVALIN rights for US, Canada & Europe.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.